Evidence map›Paper›PMID 37756698›Full record

ArticleBioinformatics (Oxford, England)2023

Extending protein interaction networks using proteoforms and small molecules.

Luis Francisco Hernández Sánchez, Bram Burger, Rodrigo Alexander Castro Campos, Stefan Johansson, Pål Rasmus Njølstad, Harald Barsnes, Marc Vaudel

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis Francisco Hernández SánchezDepartment of Clinical Science, Mohn Center for Diabetes Precision Medicine, University of Bergen, Bergen 5020, Norway.
Bram BurgerDepartment of Clinical Science, Mohn Center for Diabetes Precision Medicine, University of Bergen, Bergen 5020, Norway.ORCID 0000-0003-1093-1290
Rodrigo Alexander Castro CamposDepartamento de Sistemas, Universidad Autónoma Metropolitana Azcapotzalco, Mexico City 02128, Mexico.
Stefan JohanssonDepartment of Clinical Science, Mohn Center for Diabetes Precision Medicine, University of Bergen, Bergen 5020, Norway.ORCID 0000-0002-2298-7008
Pål Rasmus NjølstadDepartment of Clinical Science, Mohn Center for Diabetes Precision Medicine, University of Bergen, Bergen 5020, Norway.
Harald BarsnesDepartment of Biomedicine, Proteomics Unit, University of Bergen, Bergen 5020, Norway.
Marc VaudelDepartment of Clinical Science, Mohn Center for Diabetes Precision Medicine, University of Bergen, Bergen 5020, Norway.ORCID 0000-0003-1179-9578

Funding

Bergen Research FoundationNovo Nordisk Foundation NNF20OC0063872Research Council of Norway
6 · The paper itself

Abstract

motivationBiological network analysis for high-throughput biomedical data interpretation relies heavily on topological characteristics. Networks are commonly composed of nodes representing genes or proteins that are connected by edges when interacting. In this study, we use the rich information available in the Reactome pathway database to build biological networks accounting for small molecules and proteoforms modeled using protein isoforms and post-translational modifications to study the topological changes induced by this refinement of the network representation.

resultsWe find that improving the interactome modeling increases the number of nodes and interactions, but that isoform and post-translational modification annotation is still limited compared to what can be expected biologically. We also note that small molecule information can distort the topology of the network due to the high connectedness of these molecules, which does not necessarily represent the reality of biology. However, by restricting the connections of small molecules to the context of biochemical reactions, we find that these improve the overall connectedness of the network and reduce the prevalence of isolated components and nodes. Overall, changing the representation of the network alters the prevalence of articulation points and bridges globally but also within and across pathways. Hence, some molecules can gain or lose in biological importance depending on the level of detail of the representation of the biological system, which might in turn impact network-based studies of diseases or druggability. AVAILABILITY AND IMPLEMENTATION: Networks are constructed based on data publicly available in the Reactome Pathway knowledgebase: reactome.org.

Indexed as

Computational BiologyProtein Interaction MappingProtein Interaction MapsProteinsDatabases, ProteinProtein IsoformsProtein Processing, Post-TranslationalProtein IsoformsProteins

Identifiers

PMID37756698
PMCPMC10564616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.